Trials / Completed
CompletedNCT02636101
Xamiol®Gel in BODY Psoriasis: A One-year Non-interventional Study
Xamiol® Gel in BODY Psoriasis : lonG-term Management of Psoriasis vUlgARis With Xamiol® Gel in Daily Clinical Practice of Russian Dermatologists. A Long-term Observational, Prospective Study
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 603 (actual)
- Sponsor
- LEO Pharma · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
This study aims to describe the patient population treated and the real-life patients' experiences with Xamiol®gel in the long term, up to 52 weeks management of body psoriasis vulgaris in Russia. The result will increase the knowledge on Xamiol®gel enabling dermatologists and patients to optimize its use in the long term management of psoriasis.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Calcipotriol/betamethasone dipropionate gel | Topical treatment of psoriasis plaques located on the body |
Timeline
- Start date
- 2016-01-01
- Primary completion
- 2018-02-15
- Completion
- 2018-02-15
- First posted
- 2015-12-21
- Last updated
- 2019-12-13
Locations
1 site across 1 country: Russia
Source: ClinicalTrials.gov record NCT02636101. Inclusion in this directory is not an endorsement.